Covetrus Inc. [NASDAQ: CVET] surged by $4.6 during the normal trading session on Thursday and reaching a high of $38.82 during the day while it closed the day at $38.42. The company report on January 6, 2021 that Covetrus to Present at the 39th Annual J.P. Morgan Healthcare Conference.
Covetrus™ (NASDAQ: CVET), a global leader in animal-health technology and services, announced that the Company will participate in the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021. Benjamin Wolin, Covetrus’ president and chief executive officer, and Matthew Foulston, Covetrus’ executive vice president and chief financial officer, will present virtually and take analyst questions at 8:20 a.m. Eastern Time.
A live audio webcast of the event and the accompanying presentation will be available on the “Events & Presentations” section of the Company’s Investor website at https://ir.covetrus.com/investors/events-and-presentations. A replay of the presentation will also be available on this same website for approximately 90 days.
Covetrus Inc. stock has also gained 23.70% of its value over the past 7 days. However, CVET stock has inclined by 49.03% in the 3 months of the year. Over the past six months meanwhile, it has gained 85.16% and gained 33.68% year-on date.
The market cap for CVET stock reached $4.67 billion, with 116.00 million shares outstanding and 92.49 million shares in the current float. Compared to the average trading volume of 889.71K shares, CVET reached a trading volume of 1839687 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Covetrus Inc. [CVET]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CVET shares is $24.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CVET stock is a recommendation set at 2.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Stifel have made an estimate for Covetrus Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 16, 2020. While these analysts kept the previous recommendation, Goldman raised their target price to Sell. The new note on the price target was released on September 09, 2019, representing the official price target for Covetrus Inc. stock.
The Average True Range (ATR) for Covetrus Inc. is set at 1.96, with the Price to Sales ratio for CVET stock in the period of the last 12 months amounting to 1.11. The Price to Book ratio for the last quarter was 3.15, with the Price to Cash per share for the same quarter was set at 2.92. Price to Free Cash Flow for CVET in the course of the last twelve months was 146.09 with Quick ratio for the last quarter at 1.30.
CVET stock trade performance evaluation
Covetrus Inc. [CVET] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 23.70. With this latest performance, CVET shares gained by 36.97% in over the last four-week period, additionally plugging by 85.16% over the last 6 months – not to mention a rise of 167.18% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CVET stock in for the last two-week period is set at 79.36, with the RSI for the last a single of trading hit 85.56, and the three-weeks RSI is set at 74.93 for Covetrus Inc. [CVET]. The present Moving Average for the last 50 days of trading for this stock 28.38, while it was recorded at 34.01 for the last single week of trading, and 21.13 for the last 200 days.
Covetrus Inc. [CVET]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Covetrus Inc. [CVET] shares currently have an operating margin of -1.48 and a Gross Margin at +15.12. Covetrus Inc.’s Net Margin is presently recorded at -25.63.
Return on Total Capital for CVET is now -2.84, given the latest momentum, and Return on Invested Capital for the company is -51.40. Return on Equity for this stock declined to -74.12, with Return on Assets sitting at -36.43. When it comes to the capital structure of this company, Covetrus Inc. [CVET] has a Total Debt to Total Equity ratio set at 101.35. Additionally, CVET Total Debt to Total Capital is recorded at 50.34, with Total Debt to Total Assets ending up at 37.88. Long-Term Debt to Equity for the company is recorded at 94.90, with the Long-Term Debt to Total Capital now at 47.13.
Reflecting on the efficiency of the workforce at the company, Covetrus Inc. [CVET] managed to generate an average of -$185,273 per employee. Receivables Turnover for the company is 8.17 with a Total Asset Turnover recorded at a value of 1.42.Covetrus Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.30 and a Current Ratio set at 2.10.
Earnings per share (EPS) analysis for Covetrus Inc. [CVET] stock
With the latest financial reports released by the company, Covetrus Inc. posted 0.18/share EPS, while the average EPS was predicted by analysts to be reported at 0.12/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 50.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CVET.
Covetrus Inc. [CVET]: Insider Ownership positions
There are presently around $4,648 million, in the hands of institutional investors. The top three institutional holders of CVET stocks are: CLAYTON, DUBILIER & RICE, LLC with ownership of 25,430,244, which is approximately 129.665% of the company’s market cap and around 0.20% of the total institutional ownership; BLACKROCK INC., holding 14,536,301 shares of the stock with an approximate value of $558.49 million in CVET stocks shares; and VANGUARD GROUP INC, currently with $378.98 million in CVET stock with ownership of nearly -2.964% of the company’s market capitalization.
Positions in Covetrus Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 116 institutional holders increased their position in Covetrus Inc. [NASDAQ:CVET] by around 21,919,433 shares. Additionally, 118 investors decreased positions by around 11,121,014 shares, while 65 investors held positions by with 87,928,956 shares. The mentioned changes placed institutional holdings at 120,969,403 shares, according to the latest SEC report filing. CVET stock had 52 new institutional investments in for a total of 3,006,068 shares, while 33 institutional investors sold positions of 591,235 shares during the same period.